Nevertheless, the reduction in PD-1 expression and increased CD69 expression, together with the lack of strong IL-2 suppression by the 0.6 mM 2DG concentration, suggest that a low concentration of 2DG could indeed have potentially beneficial effects on anti-tumor immunity regardless of the treatment timing. This evidence concerns the gene CD69 and neoplasm.